UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet neurology, 2014-06, Vol.13 (6), p.545-556

2014

Volltextzugriff (PDF)

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

Multiple sclerosis, 2019-05, Vol.25 (6), p.819-827

2019

Volltextzugriff (PDF)

In Vivo Characterization of Retinal Microvascular Network in Multiple Sclerosis

Ophthalmology (Rochester, Minn.), 2016-02, Vol.123 (2), p.437-438

2016

Volltextzugriff (PDF)

Dimethyl fumarate for treating relapsing multiple sclerosis

Expert opinion on drug safety, 2015-01, Vol.14 (1), p.161-170

2015

Volltextzugriff (PDF)

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.209-220

2017

Volltextzugriff (PDF)

CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma

Neurology, 2012-08, Vol.79 (7), p.715-716

2012

Volltextzugriff (PDF)

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Volltextzugriff (PDF)

Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry

Neuroepidemiology, 2015-07, Vol.44 (4), p.262-268

2015

Volltextzugriff (PDF)

A dinucleotide deletion in CD24 confers protection against autoimmune diseases

PLoS genetics, 2007-04, Vol.3 (4), p.e49-e49

2007

Volltextzugriff (PDF)

Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis

Journal of clinical medicine, 2022-10, Vol.11 (20), p.6139

2022

Volltextzugriff (PDF)

Impaired retinal microcirculation in multiple sclerosis

Multiple sclerosis, 2016-12, Vol.22 (14), p.1812-1820

2016

Volltextzugriff (PDF)

Emerging multiple sclerosis oral therapies

Neurology, 2010-01, Vol.74 Suppl 1 (1_supplement_1), p.S47

2010

Volltextzugriff (PDF)

Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management

Multiple sclerosis and related disorders, 2023-11, Vol.79, p.105009-105009, Article 105009

2023

Volltextzugriff (PDF)

Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis

Expert review of neurotherapeutics, 2016-01, Vol.16 (1), p.31-44

2016

Volltextzugriff (PDF)

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis

Neurology and therapy, 2021-12, Vol.10 (2), p.415-425

2021

Volltextzugriff (PDF)

Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103254-103254, Article 103254

2021

Volltextzugriff (PDF)

CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review

Journal of neurovirology, 2014-10, Vol.20 (5), p.531-537

2014

Volltextzugriff (PDF)

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry

Neurology : neuroimmunology & neuroinflammation, 2021-09, Vol.8 (5)

2021

Volltextzugriff (PDF)

Fulminant myelitis with NMO IgG antibody following treatment with interferon alpha

Journal of neurology, 2014, Vol.261 (1), p.240-241

2014

Volltextzugriff (PDF)

The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS)

International journal of MS care, 2021-11, Vol.23 (6), p.269-275

2021

Volltextzugriff (PDF)

Longitudinal Study of Retinal Structure, Vascular, and Neuronal Function in Patients With Relapsing-Remitting Multiple Sclerosis: 1-Year Follow-Up

Translational vision science & technology, 2021-05, Vol.10 (6), p.6-6

2021

Volltextzugriff (PDF)

Vitamin B12 deficiency mimicking NMO spectrum disorder

Multiple sclerosis, 2012-11, Vol.18 (11), p.1659-1660

2012

Volltextzugriff (PDF)

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

Neurology, 2011-11, Vol.77 (21), p.1930; discussion 1930-1931

2011

Volltextzugriff (PDF)

NMO spectrum presenting as partial myelitis

Multiple sclerosis, 2013-02, Vol.19 (2), p.252-253

2013

Volltextzugriff (PDF)

Cerebrospinal fluid in multiple sclerosis

Annals of the Indian Academy of Neurology, 2009-10, Vol.12 (4), p.246-253

Rammohan, Kottil W

2009

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(67)
Berichte
(2)
Reviews
(2)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(51)
Humans
(43)
Neurosciences & Neurology
(35)
Clinical Neurology
(33)
Multiple Sclerosis
(28)
Biological And Medical Sciences
(25)
Female
(25)
Medical Sciences
(24)
Neurology
(22)
Adult
(20)
Male
(20)
Middle Aged
(20)
Magnetic Resonance Imaging
(12)
Neurosciences
(12)
General & Internal Medicine
(10)
Medicine, General & Internal
(10)
Treatment Outcome
(10)
Aged
(9)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

In Vivo Characterization of Retinal Microvascular Network in Multiple Sclerosis

Dimethyl fumarate for treating relapsing multiple sclerosis

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry

A dinucleotide deletion in CD24 confers protection against autoimmune diseases

Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis

Impaired retinal microcirculation in multiple sclerosis

Emerging multiple sclerosis oral therapies

Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management

Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis

Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients

CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry

Fulminant myelitis with NMO IgG antibody following treatment with interferon alpha

The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS)

Longitudinal Study of Retinal Structure, Vascular, and Neuronal Function in Patients With Relapsing-Remitting Multiple Sclerosis: 1-Year Follow-Up

Vitamin B12 deficiency mimicking NMO spectrum disorder

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

NMO spectrum presenting as partial myelitis

Cerebrospinal fluid in multiple sclerosis

Suchergebnisse filtern